Department of Paediatrics and Child Health, University of Queensland, Brisbane, Australia.
Pediatr Res. 2012 Nov;72(5):446-54. doi: 10.1038/pr.2012.113. Epub 2012 Aug 17.
Congenital urinary tract obstruction (diagnosed antenatally by ultrasound screening) is one of the main causes of end-stage kidney disease in children. The extent of kidney injury in early gestation and the resultant abnormality in kidney development determine fetal outcome and postnatal renal function. Unfortunately, the current approach to diagnostic evaluation of the severity of injury has inherently poor diagnostic and prognostic value because it is based on the assessment of fetal tubular function from fetal urine samples rather than on estimates of the dysplastic changes in the injured developing kidney. To improve the outcome in children with congenital urinary tract obstruction, new biomarkers reflecting these structural changes are needed. Genomic and proteomic techniques that have emerged in the past decade can help identify the key genes and proteins from biological fluids, including amniotic fluid, that might reflect the extent of injury to the developing kidney.
先天性尿路梗阻(通过超声筛查在产前诊断)是儿童终末期肾病的主要原因之一。早期妊娠时肾脏损伤的程度以及由此导致的肾脏发育异常决定了胎儿的结局和出生后的肾功能。不幸的是,目前用于评估损伤严重程度的诊断方法本身具有较差的诊断和预后价值,因为它基于从胎儿尿液样本评估胎儿肾小管功能,而不是估计受损发育中的肾脏的发育不良变化。为了改善先天性尿路梗阻患儿的预后,需要新的反映这些结构变化的生物标志物。过去十年中出现的基因组学和蛋白质组学技术可以帮助从包括羊水在内的生物液体中识别出可能反映发育中肾脏损伤程度的关键基因和蛋白质。